Given the role of MCL-1 upregulation in BCL-2 inhibitor resistance and that MCL-1 is essential for the development and growth of AML [10], MCL-1 inhibition using small molecule inhibitors has been under investigation. This evidence concerns the gene MCL1 and acute myeloid leukemia.